MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression

被引:56
作者
Sozzani, S
Introna, M
Bernasconi, S
Polentarutti, N
Cinque, P
Poli, G
Sica, A
Mantovani, A
机构
[1] MARIO NEGRI INST PHARMACOL RES, DEPT IMMUNOL & CELL BIOL, I-20157 MILAN, ITALY
[2] UNIV BRESCIA, DEPT BIOTECHNOL, SECT GEN PATHOL, BRESCIA, ITALY
[3] SAN RAFFAELE SCI INST, DIBIT, I-20132 MILAN, ITALY
关键词
chemokine receptors; natural killer cells; cytomegalovirus encephalitis;
D O I
10.1002/jlb.62.1.30
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Monocyte chemotactic protein-1 (MCP-1) interacts with the chemokine receptor CCR2, Two CCR2 cDNAs have been described, Sequence analysis as well as Northern blotting and RNase protection with different probes revealed that the CCR2 gene is expressed in activated natural killer (NK) cells and mononuclear phagocytes as a predominant long transcript (3.4 kb) consisting of CCR2B followed by a novel sequence (X), corresponding to an intron in the genome, and by a CCR2A specific portion. The predominant long transcript is polyadenylated and present in the cytoplasm, We found that bacterial products and cytokines affect CCR2 expression, Interleukin-a (IL-2) augmented CCR2 mRNA in monocytes and Nh cells, The augmented migratory capacity of IL-2-activated versus resting NK cells was associated with increased CCR2 transcript levels. Lipopolysaccharide (LPS) and other microbial agents caused a rapid and drastic reduction of CCR2 mRNA levels, The rate of nuclear transcription of CCR2 was not affected by LPS, whereas the mRNA half life was reduced, These results suggest that regulation of receptor expression, in addition to agonist production, is probably a crucial point in the regulation of the chemokine system, Down-regulation of chemokine receptor expression may play a role in the modulation of HIV infection in macrophages by LPS. Levels of MCP-1 were markedly elevated in the cerebrospinal fluid (CSF) but not in blood of HIV-infected patients with cytomegalovirus (CMV) encephalitis. The CSF levels of MCP-1 in CMV encephalitis were markedly higher than those found in the CSF of HIV-infected patients with or without unrelated neurological diseases, IL-8, the prototype of C-X-C chemokines and RANTES and macrophage inflammatory protein-1 alpha (C-C chemokines) were not substantially increased in the liquor of CMV encephalitis patients, High levels of MCP-1 may underlie monocyte recruitment and tissue damage in CMV encephalitis and may represent a rapid and useful tool in the diagnostic armamentarium for neurological disorders associated with HIV.
引用
收藏
页码:30 / 33
页数:4
相关论文
共 23 条
[1]  
Allavena P., 1996, Methods (Orlando), V10, P145, DOI 10.1006/meth.1996.0088
[2]   INDUCTION OF NATURAL-KILLER-CELL MIGRATION BY MONOCYTE CHEMOTACTIC PROTEIN-1, PROTEIN-2 AND PROTEIN-3 [J].
ALLAVENA, P ;
BIANCHI, G ;
ZHOU, D ;
VANDAMME, J ;
JILEK, P ;
SOZZANI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3233-3236
[3]  
ANDERS KH, 1986, AM J PATHOL, V124, P537
[4]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P99
[5]   Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis [J].
Bernasconi, S ;
Cinque, P ;
Peri, G ;
Sozzani, S ;
Crociati, A ;
Torri, W ;
Vicenzi, E ;
Vago, L ;
Lazzarin, A ;
Poli, G ;
Mantovani, A .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :1098-1101
[6]   ACTIVATION OF HUMAN MONOCYTE DERIVED MACROPHAGES WITH LIPOPOLYSACCHARIDE DECREASES HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION INVITRO AT THE LEVEL OF GENE-EXPRESSION [J].
BERNSTEIN, MS ;
TONGSTARKSEN, SE ;
LOCKSLEY, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :540-545
[7]   MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS [J].
CHARO, IF ;
MYERS, SJ ;
HERMAN, A ;
FRANCI, C ;
CONNOLLY, AJ ;
COUGHLIN, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2752-2756
[8]  
COMBADIERE C, 1995, J BIOL CHEM, V270, P29671
[9]  
FRANCI C, 1995, J IMMUNOL, V154, P6511
[10]  
GAO JL, 1994, J BIOL CHEM, V269, P28539